Hrain Biotechnology Overview
- Year Founded
-
2015
- Status
-
IPO Registration
- Employees
-
260
- Latest Deal Type
-
IPO
- (Announced)
- Investors
-
19
Hrain Biotechnology General Information
Description
Researcher and developer of tumor immunotherapy technologies designed to provide treatments solutions for patients. The company uses tumor immunotherapy technology with their Chimeric Antigen Receptors T (CAR-T) products to provide cancer patients with precise care and treatment, enabling clinics and hospitals to utilize innovative medical development to provide better care and treatments for their patients.
Contact Information
Website
dashengbio.comCorporate Office
- Block D, 1F, Building 1, Lane 1238, Zhangjiang Road
- Pudong New District
- Shanghai, 201203
- China
Corporate Office
- Block D, 1F, Building 1, Lane 1238, Zhangjiang Road
- Pudong New District
- Shanghai, 201203
- China
Hrain Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. IPO | 14-Oct-2022 | Announced | Clinical Trials - Phase 3 | |||
| 6. Later Stage VC (Series C) | 26-Apr-2021 | Completed | Startup | |||
| 5. Secondary Transaction - Private | 23-Dec-2020 | Completed | Startup | |||
| 4. Later Stage VC (Series B1) | 07-Sep-2020 | Completed | Startup | |||
| 3. Early Stage VC (Series B) | 13-Nov-2019 | Completed | Startup | |||
| 2. Early Stage VC | 24-Jul-2018 | Completed | Startup | |||
| 1. Early Stage VC (Series A) | 01-Mar-2018 | Completed | Startup |
Hrain Biotechnology Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | ||||||||
| Ordinary Shares |
Hrain Biotechnology Signals
Hrain Biotechnology Investors (19)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Beijing JunYuan Capital Investment Management | Growth/Expansion | Minority | ||
| Dingxiang Capital | Venture Capital | Minority | ||
| Herui Venture Capital | Growth/Expansion | Minority | ||
| October Assets | Venture Capital | Minority | ||
| Shaanxi Growth Enterprise Guide Fund | Government | Minority |
Hrain Biotechnology FAQs
-
When was Hrain Biotechnology founded?
Hrain Biotechnology was founded in 2015.
-
Where is Hrain Biotechnology headquartered?
Hrain Biotechnology is headquartered in Shanghai, China.
-
What is the size of Hrain Biotechnology?
Hrain Biotechnology has 260 total employees.
-
What industry is Hrain Biotechnology in?
Hrain Biotechnology’s primary industry is Drug Discovery.
-
Is Hrain Biotechnology a private or public company?
Hrain Biotechnology is a Private company.
-
What is Hrain Biotechnology’s current revenue?
The current revenue for Hrain Biotechnology is .
-
How much funding has Hrain Biotechnology raised over time?
Hrain Biotechnology has raised $156M.
-
Who are Hrain Biotechnology’s investors?
Beijing JunYuan Capital Investment Management, Dingxiang Capital, Herui Venture Capital, October Assets, and Shaanxi Growth Enterprise Guide Fund are 5 of 19 investors who have invested in Hrain Biotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process